Oppenheimer lowered the firm’s price target on Monroe Capital (MRCC) to $8 from $9 and keeps a Perform rating on the shares following quarterly results. The firm notes Monroe Capital lost (8c)/share in Q4, and says it estimates that it can earn $1.02/share and $1.00/share in 2025 and 2026, respectively, for an ROE of 11.5% and 11.3%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRCC:
Questions or Comments about the article? Write to editor@tipranks.com